Atlas Trials

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis.

Clinical trial NCT00036387 · COMPLETED

Trial details

NCT number
NCT00036387
Sponsor
Centocor, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Arthritis, Rheumatoid
Enrollment
347

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.